Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
46.21
+0.85 (1.87%)
At close: Feb 27, 2026, 4:00 PM EST
45.98
-0.23 (-0.50%)
After-hours: Feb 27, 2026, 7:01 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $26.66 billion as of February 27, 2026. Its market cap has increased by 90.22% in one year.
Market Cap
26.66B
Enterprise Value
34.99B
1-Year Change
90.22%
Ranking
Category
Stock Price
$46.21
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $26.66B, an increase of 69.13%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.80B | 19.92% |
| Dec 31, 2025 | 16.51B | 45.66% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.07B |
| Alnylam Pharmaceuticals | 43.93B |
| BeOne Medicines AG | 35.76B |
| Insmed | 32.33B |
| BioNTech SE | 27.30B |
| Moderna | 20.42B |
| Roivant Sciences | 20.39B |
| Revolution Medicines | 20.12B |